Interleukin Genetics Sponsors Expert Meeting on the Role of Inflammation in Aging

Interleukin Genetics, Inc. (AMEX: ILI) today announced that it is co-sponsor of "Living Well to 100: Is Inflammation Central to Aging?" on November 6-7, 2006 in Boston, MA. The conference, supported by an educational grant from Interleukin Genetics and the Nutrilite Health Institute, is organized by the Tufts Health Care Institute, an affiliate of Tufts University School of Medicine, and the Friedman School of Nutrition Science and Policy of the Jean Mayer USDA Human Nutrition Research Center on Aging.

Increasing evidence supports the role of low-grade inflammation in many of the major diseases of aging, including cardiovascular disease, Alzheimer's disease, osteoporosis and cancer. The Living Well to 100 Conference brings together leading experts from throughout the world to consider how the information on inflammation may be used to extend healthy aging. Panels of experts will address the role of inflammation in the development of common chronic diseases; inherited and environmental factors that regulate the expression of inflammation; and how lifestyle and nutrition can help individuals mitigate their risk of developing the common diseases of aging that are exacerbated by the inflammatory process.

"Excess inflammation is one of the key factors influencing an individual's risk for various diseases as they age. Interleukin Genetics has long been involved in research related to the genetics of inflammation and its role in the aging process," stated Ken Kornman, DDS, PhD Interleukin's President and Chief Scientific Officer. "We now know that these genetic factors, infant nutrition, sleep patterns, and of course adult nutrition and exercise all determine an individual's level of inflammation. Our goal is to bring genetic science to people while they are still healthy and can, through lifestyle changes, impact their over-expression of inflammation. We believe that this personalized approach has the potential to help individuals reduce pre-dispositions to medical complications later in life."

"We are proud to participate in and support this second Living Well to 100 conference," said Tim Richerson, Interleukin Genetics' CEO. "We believe this focused conference offers elite researchers in various medical science fields an important forum to discuss and explore the role of inflammation in prolonging wellness as healthy individuals age. Healthy lifestyles and nutrition can help us all reduce our disease risk as we age."

Read Full Story